Skip to content

Clinical trials

Hepatitis B trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatitis B Country / region: Australia Clear all

50 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20032
20043
20052
20074
20082
20101
20124
20131
20141
20154
20162
20183
20202
20214
20226
20244
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed31
Terminated7
Recruiting3
Active, not recruiting3
Not yet recruiting2
Unknown status2
Withdrawn2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline10
Gilead Sciences6
Kirby Institute6
Arrowhead Pharmaceuticals3
Assembly Biosciences3
Pharmasset2
Vir Biotechnology, Inc.2
bioLytical Laboratories2
Alnylam Pharmaceuticals1
Arbutus Biopharma Corporation1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatitis B50
Hepatitis B, Chronic18
Hepatitis8
HIV Infections5
Hepatitis, Chronic4
Hepatitis A2
Tetanus2
Blood-Borne Infections1
Chronic Disease1
Coinfection1

Trials

Showing 76 to 50 of 50. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.